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BACKGROUND/AIM: A recent survey (REALISETM) has revealed that patients in Europe 
perceive their asthma to be well-controlled despite the presence of symptoms. We report data 
from a similar survey of patients to assess if such discrepancy is seen in Asia. METHODS: 
Online surveys were completed by patients (aged 18-50 years, X2 prescriptions for asthma in the 
past two years), recruited via validated consumer panels from 8 countries in Asia. RESULTS: A 
total of 2,467 patients participated, split across the following geographies: Mainland China (30%), 
Hong Kong (8%), Indonesia (7%), Korea (20%), Malaysia (6%), Philippines (6%), Singapore 
(8%), and Taiwan (12%). Mean age of respondents was 34 years, with relatively equal proportion 
of males (54%) and females (46%). While 89% considered their asthma to be well-controlled, 
only 18% were classified as such according to GINA guidelines, the rest being partly controlled 
(32%) and uncontrolled (50%). In the past 7 days before completing the survey, 35% used their 
reliever inhaler X3 times, 38% experienced symptoms X3 days in a week, 64% had symptoms 
that interfere with normal activities, and 71% had night-time awakening due to asthma symptoms. 
In the past year, 33% have been hospitalized, 38% of the respondents had emergency visits, and 
73% required oral steroids for worsening asthma. Despite symptoms and exacerbations, 82% did 
not consider their asthma as serious, 80% regarded their state of health as similar as or better than 
other people their age, and 82% described themselves as confident in managing their asthma. 
Interestingly, more than 2/3 of the respondents related `control' to managing attacks rather than 
absence or minimal symptoms. Patients' definitions of well controlled asthma included: attacks 
are controllable with medical help, reduction of attacks within a time-frame, and prevention of 
attacks through lifestyle modification or alternative medicines (e.g., traditional Chinese 
medicines). CONCLUSION: Patients consistently overestimated their own asthma to be 
controlled rather than what their clinical symptoms suggested. This discrepancy may be due to 
fundamental difference on how patients define `control' which is currently geared towards 
management of exacerbation, instead of pre-defined level of symptom control. A shared 
understanding of such concepts between patients and physicians may help in achieving treatment 
goals in asthma care. DISCLOSURE: Mundipharma Pte Ltd provided funding for the survey. The 
authors received an honorarium from Mundipharma Pte Ltd for their participation in REALISE 
Asia Working Group meetings and discussions. G Neira is an employee of Mundipharma Pte Ltd. 
The REALISE Asia Working Group acknowledges Professor David Price for his advice on the 
survey and analysis of results, and Research Partnership Healthcare Asia Pte Ltd for survey 
conduct and data analysis. 
